tiprankstipranks

RxSight cuts FY25 revenue view to $160M-$175M from $185M-$197M

Consensus $190.2M. Sees FY25 operating expenses in the range of $150.0M to $160.0M, a decrease from the previous guidance range of $165.0 million to $170.0 million and now representing an implied increase of 10% to 18% compared to 2024.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue